Jelmar S. Quist
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer.
Journal: Cancer research
Published: August 30, 2024
PAK6 acts downstream of IQGAP3 to promote contractility in triple negative breast cancer cells.
Journal: Cellular signalling
Published: March 21, 2024
Correction: Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium.
Journal: Oncogene
Published: January 23, 2024
Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast Cancer.
Journal: Cancer research communications
Published: June 22, 2023
Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers.
Journal: NPJ breast cancer
Published: February 22, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 08, 2023
CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models.
Journal: Cancers
Published: April 19, 2022
TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer.
Journal: Cell reports. Medicine
Published: May 18, 2021
Random Forest Modelling of High-Dimensional Mixed-Type Data for Breast Cancer Classification.
Journal: Cancers
Published: December 28, 2020
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer.
Journal: Cancer research
Published: November 19, 2020
Last Updated: 09/26/2026